Biocryst Pharmaceuticals Inc. planned insider sales
In the last twelve months insiders at Biocryst Pharmaceuticals Inc. filed 13 Form 144 notices of planned sales, 885,375 shares worth $7.4 million at the time of filing, from 7 sellers. The latest, filed 18 May 2026: Amy McKee (director), 11,180 shares worth $99,906, planned for around 18 May 2026 through Merrill Lynch.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 18 May 2026 | Amy McKee | Director | 11,180 | $99,906 | 18 May 2026 | 11,180 shares from 18 May 2026 | Merrill Lynch | Stock Plan Activity | Form 144 |
| 13 May 2026 | Barnes Alane P | Officer | 62,500 | $596,250 | 13 May 2026 | 62,500 shares from 13 May 2026 | Fidelity Brokerage Services LLC | Option Granted - 12/20/2017 | Form 144 |
| 20 March 2026 | Heggie Theresa | Director | 49,933 | $504,620 | 20 March 2026 | 49,933 shares from 20 March 2026 | Fidelity Brokerage Services LLC | Option Granted 06/12/2024 | Form 144 |
| 16 March 2026 | Barnes Alane P | Officer | 150,000 | $1.4 million | 16 March 2026 | 150,000 shares from 16 March 2026 | Fidelity Brokerage Services LLC | Option Granted - 02/27/2017 | Form 144 |
| 2 March 2026 | Stonehouse Jon P | Director | 305,995 | $2.6 million | 2 March 2026 | No matching Form 4 sale | Fidelity Brokerage Services LLC | Option Granted - 05/23/2016 | Form 144 |
| 22 December 2025 | Barnes Alane P | Officer | 21,773 | $166,563 | 22 December 2025 | 21,773 shares from 22 December 2025 | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
| 15 December 2025 | Barnes Alane P | Officer | 21,210 | $162,256 | 15 December 2025 | 21,210 shares from 15 December 2025 | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
| 3 December 2025 | Barnes Alane P | Officer | 19,770 | $151,240 | 3 December 2025 | 70,676 shares from 2 December 2025 | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
| 2 December 2025 | Barnes Alane P | Officer | 50,906 | $367,216 | 2 December 2025 | 91,004 shares from 1 December 2025 | Fidelity Brokerage Services LLC | ESPP Purchase; Restricted Stock Vesting | Form 144 |
| 1 December 2025 | Barnes Alane P | Officer | 91,004 | $644,308 | 1 December 2025 | No matching Form 4 sale | Fidelity Brokerage Services LLC | Option Granted - 05/23/2016 | Form 144 |
| 25 November 2025 | Helen M Thackray | Officer | 48,229 | $327,957 | 25 November 2025 | No matching Form 4 sale | Merrill Lynch | Stock plan activity | Form 144 |
| 21 November 2025 | Helen Thackray | Officer | 43,275 | $307,685 | 21 November 2025 | No matching Form 4 sale | Merrill Lynch | Stock Plan Activity | Form 144 |
| 13 November 2025 | Sanders Machelle | Officer | 9,600 | $68,544 | 13 November 2025 | 9,600 shares from 13 November 2025 | Fidelity Brokerage Services LLC | Restricted Stock Vesting | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.